Use of Recombinant Human Erythropoietin in the Anemia of Progressive Renal Failure

[1]  J. Adamson,et al.  A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. , 1992, Kidney international.

[2]  J. Wetzels,et al.  Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin. , 1992, Kidney international.

[3]  G. Krejs,et al.  Need for erythropoietin treatment in predialysis patients , 1991, The Lancet.

[4]  A. Schwartz,et al.  One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis. , 1990, ASAIO transactions.

[5]  B. Wikström,et al.  The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. , 1990, British journal of clinical pharmacology.

[6]  J. Adamson,et al.  Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. , 1989, Annals of internal medicine.

[7]  R. Abels,et al.  The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  R. Degowin,et al.  The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  N. Yoshimura,et al.  Effects of recombinant human erythropoietin on the anemia of renal transplant recipients with chronic rejection. , 1989, Transplantation.

[10]  J. Adamson,et al.  Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. , 1989, The New England journal of medicine.

[11]  B. Kahan.  The impact of cyclosporine on the practice of renal transplantation. , 1989, Transplantation proceedings.

[12]  D. Hauglustaine,et al.  Haemostatic Effects of Recombinant Human Erythropoietin in Chronic Haemodialysis Patients , 1989, Thrombosis and Haemostasis.

[13]  R. Degowin,et al.  Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. , 1989, Annals of internal medicine.

[14]  T. Pincus,et al.  Treatment of the Anemia of Predialysis Patients with Recombinant Human Erythropoietin: A Randomized, Placebo‐Controlled Trial , 1988, The American journal of the medical sciences.

[15]  B. Brenner,et al.  Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Adamson,et al.  The anemia of end-stage renal disease: hematopoietic progenitor cell response. , 1988, Kidney international.

[17]  F. Wendling,et al.  Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. , 1988, The Journal of clinical investigation.

[18]  M. Koury,et al.  Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. , 1988, Blood.

[19]  C. Ponticelli,et al.  IMPROVEMENT IN THE HAEMOSTATIC DEFECT OF URAEMIA AFTER TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOIETIN , 1987, The Lancet.

[20]  J. Adamson,et al.  Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.

[21]  Robert S. Pinals,et al.  A double‐blind, placebo‐controlled trial , 1986 .

[22]  E. Eichner,et al.  Failure to diagnose anemia in medical inpatients. Is the traditional diagnosis of anemia a dying art? , 1986, The American journal of medicine.

[23]  J. Adamson,et al.  Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity. , 1986, Kidney international.

[24]  J. Adamson,et al.  The anaemia of chronic renal failure in sheep: studies in vitro , 1984, British journal of haematology.

[25]  R. McGonigle,et al.  Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. , 1984, Kidney international.

[26]  F. Molinas,et al.  The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. , 1970, The American journal of medicine.

[27]  W. Aherne.  The “Burr” Red Cell and Azotaemia , 1957, Journal of clinical pathology.

[28]  P. Mollison,et al.  Red cell life-span in nephritis and in hepatic cirrhosis. , 1953, Clinical science.

[29]  E. Friedman,et al.  Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  R. Degowin,et al.  Effect of recombinant human erythropoietin on renal function in humans. , 1990, Kidney international.

[31]  R. Asinger,et al.  Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. , 1990, American journal of nephrology.

[32]  E. Friedman,et al.  Clinical and blood rheologic stability in erythropoietin-treated predialysis patients. , 1990, American journal of nephrology.

[33]  M. Fujishima,et al.  Effects of human recombinant erythropoietin on anaemia, systemic haemodynamics and renal function in predialysis renal failure patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  R. Verberckmoes,et al.  Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  D. Peterson,et al.  Hematologic and physiologic studies during correction of anemia with recombinant human erythropoietin in predialysis patients , 1989 .

[36]  A. Hocken.  Haemolysis in chronic renal failure. , 1982, Nephron.

[37]  C. Moore,et al.  Characterization of the anemia associated with chronic renal insufficiency. , 1958, The American journal of medicine.